Exact Mass: 499.1543750000001
Exact Mass Matches: 499.1543750000001
Found 33 metabolites which its exact mass value is equals to given mass value 499.1543750000001,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cys Cys Phe Gln
Cys Cys Gln Phe
Cys Phe Cys Gln
Cys Phe Gln Cys
Cys Gln Cys Phe
Cys Gln Phe Cys
Phe Cys Cys Gln
Phe Cys Gln Cys
Phe Gln Cys Cys
Gln Cys Cys Phe
Gln Cys Phe Cys
Gln Phe Cys Cys
N-[4-(aminocarbonyl)phenyl]-4-[[1-[[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)amino]carbonyl]-2-oxopropyl]azo]benzamide
C25H21N7O5 (499.16040960000004)
Pivampicillin hydrochloride
C22H30ClN3O6S (499.1543750000001)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
(2R)-2-amino-4-{4-[(1E)-{[(3S)-1-[(R)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl}(hydroxyimino)methyl]phenoxy}butanoate
(2S)-2-amino-4-{4-[(1E)-{[(3S)-1-[(R)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl}(hydroxyimino)methyl]phenoxy}butanoate
8-chloro-1-methyl-2,6-dioxo-7H-purine-3-carboxylic acid 2-(diphenylmethyl)oxy-N,N-dimethylethanamine
C24H26ClN5O5 (499.1622376000001)
(2R)-2-amino-4-[4-[(Z)-C-[[(3S)-1-[(R)-carboxy-(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl]-N-oxidocarbonimidoyl]phenoxy]butanoic acid
(2S)-2-amino-4-[4-[(Z)-C-[[(3S)-1-[(R)-carboxy-(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl]-N-oxidocarbonimidoyl]phenoxy]butanoic acid
nocardicin A(1-)
An alpha-amino-acid anion that is the conjugate base of nocardicin A, arising from deprotonation of the carboxy groups and protonation of the amino group.
isonocardicin A(1-)
Conjugate base of isonocardicin A zwitterion where both carboxy groups are deprotonated while the homoserine amino group is protonated.
RMC-0331
C22H25ClF3N5O3 (499.15979260000006)
RMC-0331 (RM-023) is a potent, selective and orally bioavailable SOS1 inhibitor. RMC-0331 is an in vivo tool compound that blocks RAS activation via disruption of the RAS-SOS1 interaction[1].
(2s)-2-amino-4-{[(1r)-1-(carboxymethyl-c-hydroxycarbonimidoyl)-2-{[(2e)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-en-1-yl]sulfanyl}ethyl]-c-hydroxycarbonimidoyl}butanoic acid
C21H29N3O9S (499.16244240000003)
2-[6-(2,4-dihydroxy-6-methylbenzoyloxy)-4-hydroxy-5-(3-methylbut-2-en-1-yl)-1-oxo-3h-isoindol-2-yl]butanedioic acid
(2s)-4-{[(1r)-1-(carboxymethyl-c-hydroxycarbonimidoyl)-2-sulfanylethyl]-c-hydroxycarbonimidoyl}-2-{[(2e)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-en-1-yl]amino}butanoic acid
C21H29N3O9S (499.16244240000003)
2-amino-4-{[1-(carboxymethyl-c-hydroxycarbonimidoyl)-2-{[3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-en-1-yl]sulfanyl}ethyl]-c-hydroxycarbonimidoyl}butanoic acid
C21H29N3O9S (499.16244240000003)